Bio‑Neuroscience brings together senior stakeholders in CNS neuroscience drug development—including CEOs, founders, innovators, investors, policy makers and key opinion leaders. The event focuses on high-level interactive discussion, networking and partnering across the entire value chain, with the goal of accelerating innovation, translating research into therapies and achieving better patient outcomes.

Date: February 24-26, 2026
Location: Amsterdam

JOIN US!

Meet Catalent at Bio-Neuroscience 2026 to discover how our Zydis® ODT technology is transforming CNS drug delivery—enhancing patient compliance, improving outcomes and accelerating development timelines. Join us as we champion the missions that matter in neuroscience innovation and let’s work together to bring life-changing CNS treatments to patients, faster.

Complete the form to schedule a meeting with our experts!

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™